Julio E Pena-Polanco1, Maria K Mor2,3, Fadi A Tohme1, Michael J Fine2,4, Paul M Palevsky1,5, Steven D Weisbord6,2,5. 1. Renal-Electrolyte Division, Department of Medicine and. 2. Center for Health Equity Research and Promotion and. 3. Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania. 4. Division of General Internal Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania. 5. Renal Section, Medicine Service Line, Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, Pennsylvania; and. 6. Renal-Electrolyte Division, Department of Medicine and weisbordsd@upmc.edu.
Abstract
BACKGROUND AND OBJECTIVES: Depression is common in patients receiving chronic hemodialysis but seems to be ineffectively treated. We investigated the acceptance of antidepressant treatment by patients on chronic hemodialysis and their renal providers. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: As part of a clinical trial of symptom management in patients on chronic hemodialysis conducted from 2009 to 2011, we assessed depression monthly using the Patient Health Questionnaire 9. For depressed patients (Patient Health Questionnaire 9 score ≥10), trained nurses generated treatment recommendations and helped implement therapy if patients and providers accepted the recommendations. We assessed patients' acceptance of recommendations, reasons for refusal, and provider willingness to implement antidepressant therapy. We analyzed data at the level of the monthly assessment. RESULTS: Of 101 patients followed for ≤12 months, 39 met criteria for depression (Patient Health Questionnaire 9 score ≥10 on one or more assessments). These 39 patients had depression on 147 of 373 (39%) monthly assessments. At 103 of these 147 (70%) assessments, patients were receiving antidepressant therapy, and at 51 of 70 (70%) assessments, patients did not accept nurses' recommendations to intensify treatment. At 44 assessments, patients with depression were not receiving antidepressant therapy, and in 40 (91%) instances, they did not accept recommendations to start treatment. The primary reason that patients refused the recommendations was attribution of their depression to an acute event, chronic illness, or dialysis (57%). In 11 of 18 (61%) instances in which patients accepted the recommendation, renal providers were unwilling to provide treatment. CONCLUSIONS: Patients on chronic hemodialysis with depression are frequently not interested in modifying or initiating antidepressant treatment, commonly attributing their depression to a recent acute event, chronic illness, or dialysis. Renal providers are often unwilling to modify or initiate antidepressant therapy. Future efforts to improve depression management will need to address these patient- and provider-level obstacles to providing such care.
RCT Entities:
BACKGROUND AND OBJECTIVES:Depression is common in patients receiving chronic hemodialysis but seems to be ineffectively treated. We investigated the acceptance of antidepressant treatment by patients on chronic hemodialysis and their renal providers. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: As part of a clinical trial of symptom management in patients on chronic hemodialysis conducted from 2009 to 2011, we assessed depression monthly using the Patient Health Questionnaire 9. For depressedpatients (Patient Health Questionnaire 9 score ≥10), trained nurses generated treatment recommendations and helped implement therapy if patients and providers accepted the recommendations. We assessed patients' acceptance of recommendations, reasons for refusal, and provider willingness to implement antidepressant therapy. We analyzed data at the level of the monthly assessment. RESULTS: Of 101 patients followed for ≤12 months, 39 met criteria for depression (Patient Health Questionnaire 9 score ≥10 on one or more assessments). These 39 patients had depression on 147 of 373 (39%) monthly assessments. At 103 of these 147 (70%) assessments, patients were receiving antidepressant therapy, and at 51 of 70 (70%) assessments, patients did not accept nurses' recommendations to intensify treatment. At 44 assessments, patients with depression were not receiving antidepressant therapy, and in 40 (91%) instances, they did not accept recommendations to start treatment. The primary reason that patients refused the recommendations was attribution of their depression to an acute event, chronic illness, or dialysis (57%). In 11 of 18 (61%) instances in which patients accepted the recommendation, renal providers were unwilling to provide treatment. CONCLUSIONS:Patients on chronic hemodialysis with depression are frequently not interested in modifying or initiating antidepressant treatment, commonly attributing their depression to a recent acute event, chronic illness, or dialysis. Renal providers are often unwilling to modify or initiate antidepressant therapy. Future efforts to improve depression management will need to address these patient- and provider-level obstacles to providing such care.
Authors: M Blumenfield; N B Levy; B Spinowitz; C Charytan; C M Beasley; A K Dubey; R J Solomon; R Todd; A Goodman; R F Bergstrom Journal: Int J Psychiatry Med Date: 1997 Impact factor: 1.210
Authors: Steven D Weisbord; Maria K Mor; Jamie A Green; Mary Ann Sevick; Anne Marie Shields; Xinhua Zhao; Bruce L Rollman; Paul M Palevsky; Robert M Arnold; Michael J Fine Journal: Clin J Am Soc Nephrol Date: 2012-09-27 Impact factor: 8.237
Authors: S Susan Hedayati; Divya M Daniel; Scott Cohen; Bryan Comstock; Daniel Cukor; Yaminette Diaz-Linhart; Laura M Dember; Amelia Dubovsky; Tom Greene; Nancy Grote; Patrick Heagerty; Wayne Katon; Paul L Kimmel; Nancy Kutner; Lori Linke; Davin Quinn; Tessa Rue; Madhukar H Trivedi; Mark Unruh; Steven Weisbord; Bessie A Young; Rajnish Mehrotra Journal: Contemp Clin Trials Date: 2015-11-24 Impact factor: 2.226
Authors: Steven D Weisbord; Anne Marie Shields; Maria K Mor; Mary Ann Sevick; Marcia Homer; Janet Peternel; Patricia Porter; Bruce L Rollman; Paul M Palevsky; Robert M Arnold; Michael J Fine Journal: Contemp Clin Trials Date: 2010-07-01 Impact factor: 2.226
Authors: Jamie A Green; Maria K Mor; Anne Marie Shields; Mary Ann Sevik; Paul M Palevsky; Michael J Fine; Robert M Arnold; Steven D Weisbord Journal: J Palliat Med Date: 2012-02 Impact factor: 2.947
Authors: Jessica K Stevenson; Zoe C Campbell; Angela C Webster; Clara K Chow; Allison Tong; Jonathan C Craig; Katrina L Campbell; Vincent Ws Lee Journal: Cochrane Database Syst Rev Date: 2019-08-06
Authors: Diana L Vork; Terry D Schneekloth; Adam C Bartley; Lisa E Vaughan; Maria I Lapid; Sheila G Jowsey-Gregoire; Ziad M El-Zoghby; Sandra M Herrmann; Cheryl L Tran; Robert C Albright; LaTonya J Hickson Journal: Mayo Clin Proc Date: 2018-03 Impact factor: 7.616
Authors: Fadi Tohme; Maria K Mor; Julio Pena-Polanco; Jamie A Green; Michael J Fine; Paul M Palevsky; Steven D Weisbord Journal: Int Urol Nephrol Date: 2017-04-28 Impact factor: 2.370
Authors: Patrizia Natale; Suetonia C Palmer; Marinella Ruospo; Valeria M Saglimbene; Kannaiyan S Rabindranath; Giovanni Fm Strippoli Journal: Cochrane Database Syst Rev Date: 2019-12-02
Authors: Nicholas Hargrove; Nada El Tobgy; Olivia Zhou; Mark Pinder; Brittany Plant; Nicole Askin; Laura Bieber; David Collister; Reid Whitlock; Navdeep Tangri; Clara Bohm Journal: Clin J Am Soc Nephrol Date: 2021-03-25 Impact factor: 8.237
Authors: Michael J Fischer; Elani Streja; Jui-Ting Hsiung; Susan T Crowley; Csaba P Kovesdy; Kamyar Kalantar-Zadeh; Wissam M Kourany Journal: Clin Kidney J Date: 2021-06-25